{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : true,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ00937",
      "entity_text" : "CSF LRRK2",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:Q5S007",
      "entity_text" : "LRRK2",
      "features" : [ {
        "to_base" : "A",
        "site" : 0,
        "feature_type" : "mutation",
        "evidence" : "mutation"
      } ],
      "entity_type" : "protein"
    },
    "hypothesis_information" : true
  },
  "verbose_text" : "The data provided here also suggest the LRRK2 mutation alone is not sufficient to increase CSF LRRK2 since the PD- LRRK2+ group did not have significantly elevated levels compared to the healthy controls or the sporadic PD group, though a trend was observed.",
  "reading_complete" : "2020-08-05T19:58:52Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-05T19:57:38Z",
  "trigger" : "increase",
  "evidence" : [ "LRRK2 mutation alone is not sufficient to increase CSF LRRK2" ],
  "pmc_id" : "7262382",
  "score" : 0
}